IL18 and metabolic syndrome: As high levels of IL-18 have been correlated with an elevated risk of developing cardiovascular diseases, including acute myocardial infarction, and are considered a therapeutic target 30, the impact of the rs3882891 polymorphism on IL-18 expression, as well as its association with dyslipidemia, need to be elucidated in future studies.